Stay updated on Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record history was updated with new entries on 2026-03-27 and 2026-03-30. Earlier updates from 2026-03-06 and 2026-03-09 were removed.
    Difference
    0.1%
    Check dated 2026-03-31T00:37:52.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0 and the previous tag v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-23T18:10:01.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The study locations list was updated to reflect 56 sites, with additions across multiple countries and removals of several previously listed sites.
    Difference
    3%
    Check dated 2026-03-16T06:36:10.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-09T01:13:26.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no visible changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T14:09:19.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.0 to v3.4.1; no study details or user-facing functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T05:56:12.000Z thumbnail image

Stay in the know with updates to Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combo Immunotherapies vs Pembrolizumab in NSCLC Clinical Trial page.